Funder
National Natural Science Foundation of China
High-level hospital foster grants from Fujian Provincial Hospital
Natural Science Foundation of Fujian
Fujian Science and Technology Innovation Joint Fund Project
Science and Technology Department of Fujian Province
Publisher
Springer Science and Business Media LLC
Reference35 articles.
1. National Health Commission of the People’s Republic of China, Standard for diagnosis and treatment of childhood acute lymphoblastic leukemia. http://www.nhc.gov.cn/yzygj/s7653/201810/aef82930c1af4fc5bf325938e2fcb075.shtml. Accessed 16 Oct 2018.
2. Hou YJ, Zhao L, Liu XX, Ma YY. Progress of research on 6-thioguanine versus 6-mercaptopurine in childhood ALL. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2016;24(2):622–6.
3. Chiengthong K, Ittiwut C, Muensri S, Sophonphan J, Sosothikul D, Seksan P, et al. NUDT15 c.415C>T increases risk of 6-mercaptopurine induced myelosuppression during maintenance therapy in children with acute lymphoblastic leukemia. Haematologica. 2016;101(1):e24–6.
4. Present DH, Meltzer SJ, Krumholz MP, Wolke A, Korelitz BI. 6-Mercaptopurine in the management of inflammatory bowel disease: short- and long-term toxicity. Ann Intern Med. 1989;111(8):641–9.
5. Björnsson ES, Gu J, Kleiner DE, Chalasani N, Hayashi PH, Hoofnagle JH, DILIN Investigators. Azathioprine and 6-mercaptopurine-induced liver injury: clinical features and outcomes. J Clin Gastroenterol. 2017;51(1):63–9.
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献